June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Daily oxygen supplementation and risk of retinopathy of prematurity
Author Affiliations & Notes
  • Xochitl Mellor
    The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
  • Marcela Estrada
    The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
  • Lauren Tomlinson
    The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
  • Yinxi Yu
    Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Gui-Shuang Ying
    Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Gil Binenbaum
    The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
    Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Xochitl Mellor, None; Marcela Estrada, None; Lauren Tomlinson, None; Yinxi Yu, None; Gui-Shuang Ying, None; Gil Binenbaum, None
  • Footnotes
    Support  NIH 1R01EY021137-01A1, NIH 1R21EY029776-01, and the Richard Shafritz Chair in Pediatric Ophthalmology Research
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2194. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Xochitl Mellor, Marcela Estrada, Lauren Tomlinson, Yinxi Yu, Gui-Shuang Ying, Gil Binenbaum; Daily oxygen supplementation and risk of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2194.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Although higher blood oxygen saturation levels increase the risk of severe retinopathy of prematurity (ROP), complicated measures of respiratory status are impractical as screening criteria. We sought to determine if a simple, clinically useful measure of ROP risk can be developed using degree or duration of oxygen supplementation during the first month of postnatal life.

Methods : North American infants from the G-ROP-1 (29 hospitals, 2006-2012) and G-ROP-2 (41 hospitals, 2015-2017) studies with complete daily supplemental (>21%) oxygen data were studied. Associations between severe ROP and days on supplemental oxygen (DSO) during ages 0-28 days were assessed using multivariable regression, controlling for BW, GA, and other factors. Multiple screening criteria were compared: newly developed criteria incorporating DSO; G-ROP criteria, which include slow weight gain measures; G-ROP updated with DSO; and current guidelines.

Results : 8,949 infants (5,886 G-ROP-1, 3,063 G-ROP-2) were studied. 459 (5.1%) developed Type 1, 523 (5.8%) were treated. DSO during ages 0-28 days was associated with severe ROP overall (aOR 1.174 per day increase, 95%CI 1.158-1.190). The following criteria had 100% sensitivity for Type 1 and higher specificity than current guidelines: New criteria with DSO (BW<901g, GA<26 weeks, DSO>3) had 23% fewer infants examined; modified G-ROP including DSO, 29% fewer; original G-ROP, 32% fewer.

Conclusions : A simple DSO measure improves specificity but is still not as specific as the G-ROP criteria. In high-level-neonatal-care settings, incorporating simple measures of oxygen supplementation into screening criteria does not improve ROP prediction more than postnatal weight gain.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×